An alternative pathway for preclinical research in fluid management

Critical Care

Volumn 4, Issue SUPPL. 2, 2000, Pages

  Sibbald, William J ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Animal disease models; Colloids; Evidence based medicine; Randomized controlled trials; Sepsis; Serum albumin

Indexed keywords

COLLOID; ORAL REHYDRATION SOLUTION; SERUM ALBUMIN;

ANIMAL; COLLOID; DISEASE MODEL; DRUG SCREENING; ECONOMICS; EVIDENCE BASED MEDICINE; FLUID THERAPY; HUMAN; META ANALYSIS (TOPIC); METHODOLOGY; PROCEDURES; RESEARCH; SEPSIS; THERAPEUTIC USE;

ANIMALS; COLLOIDS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HUMANS; META-ANALYSIS AS TOPIC; REHYDRATION SOLUTIONS; RESEARCH; RESEARCH DESIGN; SEPSIS; SERUM ALBUMIN;

EID: 0034572907     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc970     Document Type: Article

References (35)

1. Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998, 316:961-964.
2. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998, 317:235-240.
3. Choi PT, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999, 27:200-210.
4. Roberts I, Edwards P, McLelland B: More on albumin. Use of human albumin in UK fell substantially when systematic review was published. BMJ 1999, 318:1214-1215.
5. Deitch EA: Animal models of sepsis and shock: a review and lessons learned. Shock 1998, 9:1-11.
6. Michie HP: The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother 1998, 41 (suppl A):47-49.
7. Mathiak G, Szewczyk D, Abdullah F, et al: An improved clinically relevant sepsis model in the conscious rat. Crit Care Med 2000, 28:1947-1952.
8. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor a in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995, 273:934-941.
9. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 1996, 24:733-742.
10. Teng NN, Kaplan HS, Hebert JM, et al: Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci USA 1985, 82:1790-1794.
11. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebocontrolled trial. N Engl J Med 1991, 324:429-436.
12. Quezado ZM, Natanson C, Alling DW, et al: A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 1993, 269:2221-2227.
13. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994, 121: 1-5.
14. Rennick DM, Fort MM: Lessons from genetically engineered animal models. XII. lL-10-deficient (IL-10(-/-)) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000, 278:G829-G833.
15. Piper RD, Cook DJ, Bone RC, Sibbald WJ: Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 1996, 24:2059-2070.
16. Drews J, Ryser S: The role of innovation in drug development Nat Biotechnol 1997,15:1318-1319.
17. Cook DJ, Sackett DL, Spitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 1995,48:167-171.
18. Stroup DF, Berlin JA, Morton SC, et al: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012.
19. Freedman LS: Meta-analysis of animal experiments on dietary fat intake and mammary tumours. Stat Med 1994, 13:709-718.
20. Freedman LS, Clifford CK: Meta-analysis of animal experiments: elucidating relationships between dietary fat and mammary tumor development in rodents. Adv Exp Med Biol 1994, 364:93-100.
21. McKnight B: Considerations in the conduct of meta-analysis using data from animal carcinogenicity experiments. IARC Sci Publ 1992, 116:557-569.
22. Valberg PA, Crouch EA: Meta-analysis of rat lung tumors from lifetime inhalation of diesel exhaust. Environ Health Perspect 1999, 107:693-699.
23. Perna A, Remuzzi G: Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies. Am J Kidney Dis 1996, 27:34-41.
24. Benignus VA, Boyes WK, Bushnell PJ: A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans. Toxicol Sci 1998,43:186-195.
25. Craig JC, Wheeler DM, Irwig L, Howman-Giles RB: How accurate is dimercaptosuccinic acid scintigraphy for the diagnosis of acute pyelonephritis? A meta-analysis of experimental studies. J Nucl Med 2000, 41:986-993.
26. Bardo MT, Rowlett JK, Harris MJ: Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 1995, 19:39-51.
27. Kelley G: Mechanical overload and skeletal muscle fiber hyperplasia: a meta-analysis. J Appl Physiol 1996, 81:1584-1588.
28. Linde K, Jonas WB, Melchart D, et al: Critical review and metaanalysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 1994, 13:481-492.
29. Wilson MA, Chou MC, Spain DA, et al: Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma 1996, 41:622-627.
30. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
31. Doig GS, Martin CM, Sibbald WJ: Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis. Crit Care Med 1997, 25:1956-1961.
32. Morisaki H, Bloos F, Keys J, et al: Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury In septic sheep. J Appl Physiol 1994, 77:1507-1518.
33. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269:3024-3029.
34. Silverman HJ, Tuma P: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992,102:184-188.
35. Fitzgerald RD, Martin CM, Dietz GE, et al: Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 1997, 25:726-732.